Yantai, China

Guangying Du

This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Luye Innomind Pharma Shijiazhuang Co., Ltd.. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Guangying Du. Retrieved from https://idiyas.com/inventor/guangying-du

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 8.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Guangying Du

Introduction

Guangying Du is a notable inventor based in Yantai, China. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that serve as VMAT2 inhibitors. His work is crucial for advancing treatments for diseases related to VMAT2.

Latest Patents

One of Guangying Du's key patents is titled "VMAT2 inhibitor and preparation method therefor and application thereof." This invention relates to a class of compounds that act as VMAT2 inhibitors. It specifically focuses on a compound represented by a particular formula, including its stereoisomers and pharmaceutically acceptable salts. The patent also details the preparation method and its application in creating medicaments for treating diseases associated with VMAT2.

Career Highlights

Guangying Du is currently employed at Luye Innomind Pharma Shijiazhuang Co., Ltd. His role at the company allows him to leverage his expertise in pharmaceutical innovations. With a patent portfolio that includes 1 patent, he continues to contribute to the advancement of medical science.

Collaborations

Some of his notable coworkers include Liang Ye and Jingwei Tian. Their collaboration enhances the innovative environment at Luye Innomind Pharma, fostering the development of new therapeutic solutions.

Conclusion

Guangying Du's work exemplifies the impact of innovative thinking in the pharmaceutical industry. His contributions, particularly in the area of VMAT2 inhibitors, are paving the way for new treatments and advancements in medicine.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…